DK190989D0 - Fremgangsmaade til fremstilling af antigener - Google Patents

Fremgangsmaade til fremstilling af antigener

Info

Publication number
DK190989D0
DK190989D0 DK190989A DK190989A DK190989D0 DK 190989 D0 DK190989 D0 DK 190989D0 DK 190989 A DK190989 A DK 190989A DK 190989 A DK190989 A DK 190989A DK 190989 D0 DK190989 D0 DK 190989D0
Authority
DK
Denmark
Prior art keywords
adenylate cyclase
preparation
calmodulin
pertussis
kda
Prior art date
Application number
DK190989A
Other languages
English (en)
Other versions
DK175663B1 (da
DK190989A (da
Inventor
Murielle Rocancourt
Colette Brezin
Jean-Luc Boucaud
Marek Szatanik
Jean-Michel Alonso
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of DK190989D0 publication Critical patent/DK190989D0/da
Publication of DK190989A publication Critical patent/DK190989A/da
Application granted granted Critical
Publication of DK175663B1 publication Critical patent/DK175663B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198901909A 1988-04-19 1989-04-19 Fremgangsmåde til opnåelse af beskyttende antigener mod Bordetalla-infektioner og toxiske processer DK175663B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88400949 1988-04-19
EP88400949A EP0338169B1 (en) 1988-04-19 1988-04-19 Method for obtaining protective antigens against bordetella infections and toxic processes

Publications (3)

Publication Number Publication Date
DK190989D0 true DK190989D0 (da) 1989-04-19
DK190989A DK190989A (da) 1989-10-20
DK175663B1 DK175663B1 (da) 2005-01-10

Family

ID=8200381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901909A DK175663B1 (da) 1988-04-19 1989-04-19 Fremgangsmåde til opnåelse af beskyttende antigener mod Bordetalla-infektioner og toxiske processer

Country Status (10)

Country Link
US (1) US5595901A (da)
EP (2) EP0691348A1 (da)
JP (1) JP2999480B2 (da)
AT (1) ATE140729T1 (da)
CA (1) CA1341332C (da)
DE (1) DE3855442T2 (da)
DK (1) DK175663B1 (da)
ES (1) ES2091186T3 (da)
GR (1) GR3021331T3 (da)
PT (1) PT90310B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DK1790344T3 (da) 2000-07-07 2011-05-02 Spectrum Pharmaceuticals Inc Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2606789B1 (fr) * 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
US5312749A (en) * 1992-05-12 1994-05-17 The United States Of America As Represented By The Secretary Of Agriculture Industrial alkaline protease from shipworm bacterium

Also Published As

Publication number Publication date
ES2091186T3 (es) 1996-11-01
DK175663B1 (da) 2005-01-10
ATE140729T1 (de) 1996-08-15
DE3855442T2 (de) 1997-03-06
DK190989A (da) 1989-10-20
GR3021331T3 (en) 1997-01-31
JPH02131432A (ja) 1990-05-21
EP0691348A1 (en) 1996-01-10
CA1341332C (en) 2002-01-08
DE3855442D1 (de) 1996-08-29
US5595901A (en) 1997-01-21
EP0338169A1 (en) 1989-10-25
EP0338169B1 (en) 1996-07-24
JP2999480B2 (ja) 2000-01-17
PT90310B (pt) 1994-09-30
PT90310A (pt) 1989-11-10

Similar Documents

Publication Publication Date Title
DK190989D0 (da) Fremgangsmaade til fremstilling af antigener
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
NO20003716D0 (no) Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
KR900700132A (ko) 면역 글로불린 e 반응 억제 방법
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
FI873410A (fi) Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita
Agui et al. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes
DE3885365D1 (de) Spezifische Sekretions-Exkretions-Antigene von Toxoplasma gondii, deren Expressionsprodukte, Verfahren zu deren Herstellung und deren diagnostische und prophylaktische Anwendungen.
DK81691D0 (da) Fremgangsmaade til forhindring eller reduktion af eosinofili
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
DK270389A (da) Lyofiliseret igm-koncentrat
EP0331327A3 (en) Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption
SE9300139L (sv) Framställning av ett nytt läkemedel
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ES546594A0 (es) Un procedimiento para preparar un anticuerpo monocional anti-urocinasa.
Ostermann-Latif et al. An efficient sandwich-ELISA for the determination of choline acetyltransferase
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK